Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · IEX Real-Time Price · USD
2.470
+0.220 (9.78%)
At close: May 17, 2024, 4:00 PM
2.360
-0.110 (-4.45%)
After-hours: May 17, 2024, 7:51 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $64.45 million as of May 17, 2024. Its market cap has increased by 112.01% in one year.
Market Cap
64.45M
Enterprise Value
36.22M
1-Year Change
112.01%
Ranking
Category
Stock Price
$2.47
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $64.45M, a decrease of -1.97%. That is a compound annual growth rate of -0.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 65.20M | 9.76% |
| May 16, 2024 | 59.40M | -4.35% |
| May 15, 2024 | 62.10M | 6.88% |
| May 14, 2024 | 58.10M | 1.75% |
| May 13, 2024 | 57.10M | -0.87% |
| May 10, 2024 | 57.60M | - |
| May 9, 2024 | 57.60M | 29.44% |
| May 8, 2024 | 44.50M | 1.37% |
| May 7, 2024 | 43.90M | -5.18% |
| May 6, 2024 | 46.30M | -0.86% |
| May 3, 2024 | 46.70M | 1.74% |
| May 2, 2024 | 45.90M | 6.50% |
| May 1, 2024 | 43.10M | - |
| Apr 30, 2024 | 43.10M | 2.38% |
| Apr 29, 2024 | 42.10M | -0.47% |
| Apr 26, 2024 | 42.30M | 1.44% |
| Apr 25, 2024 | 41.70M | -1.42% |
| Apr 24, 2024 | 42.30M | -7.44% |
| Apr 23, 2024 | 45.70M | 8.04% |
| Apr 22, 2024 | 42.30M | -2.76% |
| Apr 19, 2024 | 43.50M | -0.91% |
| Apr 18, 2024 | 43.90M | -11.67% |
| Apr 17, 2024 | 49.70M | -2.74% |
| Apr 16, 2024 | 51.10M | -3.22% |
| Apr 15, 2024 | 52.80M | -3.65% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DIH Holdings US | 64.47M |
| Ikena Oncology | 64.42M |
| AEON Biopharma | 63.16M |
| vTv Therapeutics | 62.96M |
| Hyperfine | 62.65M |
| AVROBIO | 61.50M |
| Anebulo Pharmaceuticals | 61.20M |
| Theratechnologies | 61.15M |